Psoriatic arthritis is a chronic autoimmune condition that affects millions, causing joint pain, stiffness, and skin plaques. While there is no cure, advances in treatment—particularly biologic therapy—have revolutionized disease management. In this guide, we’ll explore the latest options, from Humira to Skyrizi, and how they can help you regain control.

Understanding Psoriatic Arthritis

Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis, a skin condition. According to the Arthritis Foundation, up to 30% of people with psoriasis will develop PsA. It can cause joint pain, stiffness, swelling, and fatigue, often affecting the fingers, toes, and spine. Early diagnosis and treatment are crucial to prevent joint damage and maintain quality of life.

How Biologic Therapy Can Help

Biologic therapy represents a significant advancement in treating psoriatic arthritis. Unlike traditional systemic medications, biologics are proteins engineered to target specific parts of the immune system that drive inflammation. The National Institutes of Health notes that these treatments can reduce symptoms, improve physical function, and slow disease progression for many people. They are often prescribed when conventional therapies like NSAIDs or disease-modifying antirheumatic drugs (DMARDs) are insufficient. Because biologics suppress the immune system, regular monitoring by a rheumatologist is essential to manage risks.

Top Biologic Therapies for Psoriatic Arthritis

Several advanced therapies are FDA-approved for psoriatic arthritis, offering various mechanisms of action. The U.S. Food and Drug Administration has rigorously evaluated these treatments for safety and efficacy. While Rinvoq and Xeljanz are targeted synthetic DMARDs rather than biologics, they are included here as they represent modern options for active disease. Here are some commonly prescribed options:

  • Humira (adalimumab): A TNF inhibitor that helps reduce inflammation and can slow joint damage.
  • Enbrel (etanercept): Another TNF inhibitor, often used for moderate to severe psoriatic arthritis.
  • Skyrizi (risankizumab): An IL-23 inhibitor that can clear skin plaques and improve joint symptoms.
  • Rinvoq (upadacitinib): A JAK inhibitor taken orally, offering an alternative for those who prefer pills over injections.
  • Xeljanz (tofacitinib): Another JAK inhibitor that may be effective when other treatments have not worked.

Each treatment has unique benefits and potential side effects, so a personalized approach is key.

Choosing the Right Treatment for You

Selecting a treatment plan involves considering factors like disease severity, lifestyle, and insurance coverage. A rheumatologist can help weigh options, often starting with methotrexate before advancing to biologics if needed. Shared decision-making ensures the therapy aligns with your goals and comfort levels. For additional support, the National Psoriasis Foundation offers educational resources and a directory of specialists.

Living with psoriatic arthritis can be challenging, but staying informed empowers you to take an active role in your care. Whether considering Humira, Skyrizi, or other options, discussing biologic therapy with your doctor can open doors to better symptom management. Take the next step by scheduling an appointment with a rheumatologist to explore the best path forward for you.